Science
Extensive Study Identifies Over a Dozen Existing Drugs as Potential COVID-19 Therapies – Global Health News Wire
Mining the world’s most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral…
A researcher at Calibr, the drug discovery division of Scripps Research, working in the high-throughput screening facility used to identify potential COVID-19 therapies.
Mining the world’s most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that’s driving the ongoing global pandemic.
Among those compounds, the Scripps Research study identified four clinically approved…
Continue Reading
